Atlas Trials

Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]

Clinical trial NCT03428607 · COMPLETED

Trial details

NCT number
NCT03428607
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SCLC
Start date
2018-10-17
Primary completion
2021-01-15
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.